| Dr Shawn M Wiggins, MD | |
|
Two Hurley Plaza, Suite 204, Flint, MI 48503 | |
| (810) 262-6743 | |
| (810) 235-1210 |
| Full Name | Dr Shawn M Wiggins |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | Two Hurley Plaza, Flint, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376691147 | NPI | - | NPPES |
| 4455439 | Medicaid | MI | |
| M32030078 | Other | MI | MEDICARE GROUP OM 32030 |
| 70-0-B5-1070-0 | Other | MI | BCBSM GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301072235 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hurley Medical Center | Flint, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hamilton Community Health Network Inc | 1254249196 | 33 |
| Hurley Health Services | 4082609151 | 5 |
| Hurley Medical Center | 2961308481 | 264 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
| Entity Name | Hamilton Community Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386624278 PECOS PAC ID: 1254249196 Enrollment ID: O20031203000286 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
| Entity Name | Hurley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982630844 PECOS PAC ID: 2961308481 Enrollment ID: O20031208000375 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
| Entity Name | Hurley Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558302497 PECOS PAC ID: 4082609151 Enrollment ID: O20040417000547 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
| Entity Name | Obhg Michigan, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790120863 PECOS PAC ID: 3971739244 Enrollment ID: O20131114000576 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shawn M Wiggins, MD Two Hurley Plaza, Suite 204, Flint, MI 48503 Ph: (810) 262-6743 | Dr Shawn M Wiggins, MD Two Hurley Plaza, Suite 204, Flint, MI 48503 Ph: (810) 262-6743 |
News Archive
Researchers from the University of Texas at Austin have invented a pen-like, handheld device that can identify cancerous tissue in around 10 seconds during surgery, offering hope that procedures to remove cancer could be made quicker, more precise and safer.
Savient Pharmaceuticals, Inc. reported financial results for the three and nine months ended September 30, 2011, which reflect the Company's continuing investment in the U.S. launch of KRYSTEXXA (pegloticase). Savient ended the quarter with $202.7 million in cash and short-term investments, a decrease of $37.6 million for the quarter.
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving University of Rochester Medical Center researchers.
A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.
› Verified 4 days ago
Dr. Larry J Young, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Two Hurley Plaza, Suite 204, Flint, MI 48503 Phone: 810-262-6743 Fax: 810-235-1210 | |
Dr. David H Pyatt, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 Mason St, Flint, MI 48503 Phone: 810-496-5777 | |
Anton Strocel, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1402 W Court St, Flint, MI 48503 Phone: 810-767-3220 Fax: 810-767-7969 | |
Sierra Cuthpert, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Hurley Plz, Flint, MI 48503 Phone: 810-262-6426 | |
Alexey A Levashkevich, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1010 N Linden Rd, Flint, MI 48532 Phone: 810-732-3660 Fax: 810-732-1082 | |
Dr. Phillip H. Hardy Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Hurley Plz, Flint, MI 48503 Phone: 810-257-9000 Fax: 810-760-0440 | |
Dr. Lauryn Lynn Przeslawski, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1314 S Linden Rd, Flint, MI 48532 Phone: 810-342-1700 Fax: 810-720-4035 |